Literature Review - Methadone Maintenance Treatment

Reference List

• Abbott, P.J., Moore, B.A., Weller, S.B, and Delaney, H.D. (1998). AIDS risk behaviour in opioid-dependent patients treated with Community Reinforcement Approach and relationships with psychiatric disorders. Journal of Addictive Diseases, 17 (4), 33-48.
  
  
• Belding, M.A., McLellan, T., Zanis, D.A., and Incmikosk, R. (1998). Characterizing "nonresponsive" methadone patients. Journal of Substance Abuse Treatment, 15 (6), 485-492.
  
  
• Bell, J. (1998a). Delivering effective methadone treatment. In J. Ward, R. P. Mattick, and W. Hall (Eds.), Methadone Maintenance Treatment and Other Opioid Replacement Therapies (pp. 161-175). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  
  
• Bell, J. (1998b). Staff training in methadone clinics. In J. Ward, R.P. Mattick, and W. Hall (Eds.), Methadone Maintenance Treatment and other Opioid Replacement Therapies (pp. 361-377). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  
  
• Best, D., Glossop, M., Greenwood, J., Marsden, J., Lehman, P., and Strung, J. (1999). Cannabis use in relation to illicit drug use and health problems among opiate misusers in treatment. Drug and Alcohol Review, 18, 31-38.
  
  
• Best, D., Lehmann, P., Glossop, M., Harris, J., Noble, A., and Strung, J. (1998). Eating too little, smoking and drinking too much: Wider lifestyle problems among methadone maintenance patients. Addiction Research, 00, 1-10.
  
  
• Brands, B., and Brands, J. (Eds.) (1998). Methadone Maintenance: A Physician's Guide to Treatment. Toronto: Addiction Research Foundation, Centre for Addiction and Mental Health.
  
  
• Brands, B., Kahan, M., Selby, P., and Wilson, L. (Eds.). (2000). Management of Alcohol, Tobacco and Other Drug Problems. Toronto: Centre for Addiction and Mental Health.
  
  
• Brands, J., and Janecek, E. (Eds.). (2000). Methadone Maintenance: A Pharmacist's Guide to Treatment. Toronto: Centre for Addiction and Mental Health.
  
  
• Broers, B., Junet, C., Bourquin, M., Déglon, J.J., Perrin, L., and Hirschel, B. (1998). Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995. AIDS, 12 (15), 2059-2066.
  
  
• Broome, K.M., Simpson, D.D., and Joe, G.W. (1999). Patient and program attributes related to treatment process indicators in DATOS. Drug and Alcohol Dependence, 57, 127-135.
  
  
• Budney, A. J., Bickel, W. K., and Amass, L. (1998). Marijuana use and treatment outcome among opioid-dependent patients. Addiction, 93(4), 493-503
  
  
• Canadian Association for Study of the Liver (CASL) Consensus Conference Rapporteur Group. (2000). Canadian Consensus Conference on the Management of Viral Hepatitis. Canadian Journal of Gastroenterology, 14 (Supplement B Current Issues in the Management of Viral Hepatitis), 5B-20B.
  
  
• Canadian Centre on Substance Abuse and Canadian Public Health Association (1997). HIV/AIDS and Injection Drug Use: A National Action Plan. Ottawa: Authors.
  
  
• Canadian Centre on Substance Abuse and Centre for Addiction and Mental Health (1999). Canadian Profile: Alcohol, Tobacco and Other Drugs 1999. Ottawa and Toronto: Authors
  
  
• Canadian HIV-AIDS Legal Network (1999). Injection Drug Use and HIV/AIDS: Legal and Ethical Issues. Montreal: Author.
  
  
• Canadian HIV/AIDS Legal Network and Canadian AIDS Society (1996). HIV/AIDS in Prisons: Final Report. Prepared by Ralf Jurgens. Montreal: Authors.
  
  
• Caplehorn, J. R. M., Lumley, T. S., and Irwig, L. (1998). Staff attitudes and retention of patients in methadone maintenance programs. Drug and Alcohol Abuse, 52(1), 57-61.
  
  
• Correctional Service Canada (October 1998). National Methadone Maintenance Treatment Program Phase 1: Resource and Information Package.
  
  
• Crofts, N., Nigro, L., Oman, K., Stevenson, E., and Sherman, J. (1997). Methadone maintenance and hepatitis C virus infection among injecting drug users. Addiction, 92 (8), 999-1005.
  
  
• Darke, S. (1998a). Self-report among injecting drug users: A review. Drug and Alcohol Dependence, 51(3), 253-263
  
  
• Darke, S. (1998b). The effectiveness of methadone maintenance treatment 3: Moderators of treatment outcome. In J. Ward, R. P. Mattick, and W. Hall (Eds.), Methadone Maintenance Treatment and Other Opioid Replacement Therapies (pp. 75-89). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  
  
• Darke, S., Kaye, S., and Finlay-Jones, R. (1998). Antisocial personality disorder, psychopathy and injecting heroin use. Drug and Alcohol Dependence, 52, 63-69.
  
  
• Darke, S., Hall, W., and Swift, W. (1994). Prevalence, symptoms and correlates of antisocial personality disorder among methadone maintenance clients. Drug and Alcohol Dependence, 34, 253-257.
  
  
• Dazord, A., Mino, A., Page, D., and Broers, B. (1998). Patients on methadone maintenance treatment in Geneva. Eur Psychiatry, 13, 235-241.
  
  
• D'Ippoliti, D., Davoli, M., Perucci, C. A., Pasqualini, F., and Bargagli, A. M. (1998). Retention in treatment of heroin users in Italy: The role of treatment type and of methadone maintenance dosage. Drug and Alcohol Dependence, 52(2), 167-171.
  
  
• Dolan, K., Hall, W., and Wodak, A. (1998). The provision of methadone in prison settings. In J. Ward, R. P. Mattick, and W. Hall (Eds.), Methadone Maintenance Treatment and Other Opioid Replacement Therapies (pp. 379-396). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  
  
• DuPont, R. L., and Baumgartner, W. A. (1995). Drug testing by urine and hair analysis: complementary features and scientific issues. Forensic Science International, 70, 63-76.
  
  
• Fingerhood, M .I. (1999). Comorbid medical disorders. In E. C. Strain and M. L. Stitzer (Eds.), Methadone Treatment for Opioid Dependence (pp. 118-140). Baltimore: The Johns Hopkins University Press.
  
  
• Finnegan, L.P. (1991). Treatment issues for opioid-dependent women during the prenatal period. Journal of Psychoactive Drugs, 23 (2), 191-201.
  
  
• Fletcher, B.W., and Battjes, R.J. (1999). Introduction to the special issue: treatment process in DATOS. Drug and Alcohol Dependence, 57, 81-87.
  
  
• Gilbert, L., El-Bassel, N., Rajah, V., Foleno, A., Fontdevila, J, Frye, V., and Richmand, B.L. (2000). The converging epidemics of mood-altering-drug use, HIV, HCV, and partner violence. The Mount Sinai Journal of Medicine, 67 (5 and 6), 452-463.
  
  
• Glezen, L. A., and Lowery, C. A. (1999). Practical issues of program organization and operation. In E. C. Strain and M. L. Stitzer (Eds.), Methadone Treatment for Opioid Dependence (pp. 223-249). Baltimore: The Johns Hopkins University Press.
  
  
• Gourevitch, M.N., and Friedland, G.H. (2000). Interactions between methadone and medications used to treat HIV infection: A review. The Mount Sinai Journal of Medicine, 67 (5 and 6), 429-436.
  
  
• Hagan, H., and Des Jarlais, D.C. (2000). HIV and HCV infection among injecting drug users. The Mount Sinai Journal of Medicine, 67 (5 and 6), 423-428.
  
  
• Hall, W., Ward, J., and Mattick, R. P. (1998a). Introduction. In J. Ward, R. P. Mattick, and W. Hall (Eds.), Methadone Maintenance Treatment and Other Opioid Replacement Therapies (pp. 1-14). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  
  
• Hall W., Ward, J., and Mattick, R. P. (1998b). The effectiveness of methadone maintenance treatment 1: Heroin use and crime. In J. Ward, R.P. Mattick, and W. Hall (Eds.), Methadone Maintenance Treatment and Other Opioid Replacement Therapies (pp. 17-57). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  
  
• Hartel, D.M., and Schoenbaum E.E. (1998). Methadone treatment protects against HIV infection: Two decades of experience in the Bronx, New York City. Public Health Reports, 113 (Supplement 1), 107-115.
  
  
• Health Canada (2002a). Best Practices in the Design and Delivery of Methadone Maintenance Treatment. Ottawa: Minister of Public Works and Government Services.
  
  
• Health Canada (2002b). Methadone Maintenance Treatment (Brochure). Ottawa: Minister of Public Works and Government Services.
  
  
• Health Canada (2001). Guidelines for Best Practices for the Treatment and Rehabilitation of Women with Substance Use Problems. Ottawa: Minister of Public Works and Government Services.
  
  
• Health Canada (2000a). Profile of Hepatitis C and Injection Drug Use in Canada: A Discussion Paper. Prepared for Hepatitis C Prevention, Support and Research Program, Population and Public Health Branch, Health Canada, September 2000 by Jamie Wieb and Bette Reimer, on behalf of the Canadian Centre on Substance Abuse.
  
  
• Health Canada (2000b). Mediums to Reach Injection Drug Using Populations: A Discussion Paper. Prepared for Hepatitis C Prevention, Support and Research Program, Population and Public Health Branch, Health Canada, September 2000 by Jamie Wieb and Bette Reimer, on behalf of the Canadian Centre on Substance Abuse.
  
  
• Health Canada (1999a). Best Practices - Substance Abuse Treatment and Rehabilitation. Ottawa: Minister of Public Works and Government Services Canada.
  
  
• Health Canada (1999b). HIV/AIDS among injection drug users in Canada. HIV/AIDS Epi Update May 1999. Bureau of HIV/AIDS, STD and TB Update Series. Laboratory Centre for Disease Control.
  
  
• Health and Welfare Canada (1992) The Use of Opioids in the Management of Opioid Dependence. Ottawa: Minister of National Health and Welfare.
  
  
• Jarvis, M.A.E., and Schnoll, S.H. (1994). Methadone treatment during pregnancy. Journal of Psychoactive Drugs, 26 (2), 155-161.
  
  
• Joe, G.W., Simpson, D.D., and Broome, K.M. (1999). Retention and patient engagement models for different treatment modalities in DATOS. Drug and Alcohol Dependence, 57, 113-125.
  
  
• Jones, H. E., Velex, M. L., McCaul, M. E., and Svikis, D. S. (1999). Special treatment issues for women. In E. C. Strain and M. L. Stitzer (Eds.), Methadone Treatment for Opioid Dependence (pp. 251-280). Baltimore: The Johns Hopkins University Press.
  
  
• Joseph, H., Stancliff, S., and Langrod, J. (2000). Methadone maintenance treatment (MMT): A review of historical and clinical issues. The Mount Sinai Journal of Medicine 67 (5 and 6), 347-364.
  
  
• Kaltenbach, K., Berghella, V., and Finnegan, L. (1998). Opioid dependence during pregnancy. Effects and management. Obstetrics and Gynecology Clinics of North America, 25(1), 139-151.
  
  
• Kandall, S. R., Doberczak, T. M., Jantunen, M., and Stein, J. (1999). The methadone-maintained pregnancy. Clinics in Perinatology, 26(1), 173-183.
  
  
• Kidorf, M., King, V. L., and Brooner, R. K. (1999). Integrating psychosocial services with methadone treatment: Behaviorally contingent pharmacotherapy. In E. C. Strain and M. L. Stitzer (Eds.), Methadone Treatment for Opioid Dependence (pp.166-195). Baltimore: The Johns Hopkins University Press.
  
  
• King, V. L., and Brooner, R. K. (1999). Assessment and treatment of comorbid psychiatric disorders. In E.C. Strain and M..L. Stitzer (Eds.), Methadone Treatment for Opioid Dependence (pp. 141-165). Baltimore: The Johns Hopkins University Press.
  
  
• Langendam, M. W., Van Haastrecht, H. J. A., Van Brussel, G. H. A., Reurs, H., Van Den Hoek, A. J. A. R., Coutinho, R. A., and Van Ameijden, E. J. C. (1998). Differentiation in the Amsterdam methadone dispensing circuit: Determinants of methadone dosage and site of methadone prescription. Addiction, 93(1), 61-72.
  
  
• Leavitt, S., Shinderman, M., Maxwell, S., Chin, B., and Paris, P. (2000). When "enough" is not enough: New perspectives on optimal methadone maintenance dose. The Mount Sinai Journal of Medicine, 67 (5 and 6), 404-411.
  
  
• Leshner, A.I. (1999). Science-based views of drug addiction and treatment. JAMA, [On-line] 282(14).
  
  
• Lindesmith Centre, The. (1997). Methadone Maintenance Treatment.[Brochure]. New York and San Francisco: Author.
  
  
• Longshore, D., Hsieh, S., and Anglin, M.D. (1994). Reducing HIV risk behavior among injection drug users: Effect of methadone maintenance treatment on number of sex partners. The International Journal of the Addictions, 29 (6), 741-757.
  
  
• Lowinson, J. H., Payte, J. T., Salsitz, E., Joseph, H., Marion, I. J., and Dole, V. P. (1997.) Methadone maintenance. In J. H. Lowinson, J. T. Payte, E. Salsitz, H. Joseph, I. J. Marion, and V. P. Dole (Eds.), Substance Abuse: A Comprehensive Text (3rd ed.., pp. 405-415). Baltimore: Williams and Wilkins.
  
  
• Magura, S., Nwakeze, P. C., and Demsky, S. (1998a). Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction, 93(1), 51-60.
  
  
• Magura, S., Rosenblum, A., and Rodriguez, E. M. (1998b). Changes in HIV risk behaviors among cocaine-using methadone patients. Journal of Addictive Diseases, 17(4), 71-90.
  
  
• Marsch, L. (1998). The efficacy of methadone maintenance intervention in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction, 93(4), 515-32.
  
  
• Mattick, R.P., Ward, J., and Hall, W. (1998). The role of counselling and psychological therapy. In J. Ward, R..P. Mattick, and W. Hall (Eds.), Methadone Maintenance Treatment and Other Opioid Replacement Therapies (pp. 265-304). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  
  
• McPhilips, M. A., Strang, J., and Barnes, T. R. E. (1998). Hair analysis. New laboratory ability to test for substance use. British Journal of Psychiatry, 173, 287-289.
  
  
• National Institute on Drug Abuse (1995). Methadone Maintenance Treatment: Translating Research into Policy. Bethesda, MD: Author.
  
  
• National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction (1998). Effective medical treatment of opiate addiction. JAMA, 280(22), 1936-1943.
  
  
• Novick, D.M. (2000). The Impact of Hepatitis C Virus Infection on Methadone Maintenance Treatment. The Mount Sinai Journal of Medicine, 67 (5 and 6), 437-443.
  
  
• Robles, E., Silverman, K., and Stitzer, M. L. (1999). Contingency management therapies. In E.C. Strain and M. L. Stitzer (Eds.), Methadone Treatment for Opioid Dependence (pp. 196-222). Baltimore: The Johns Hopkins University Press.
  
  
• Rothbard, A., Alterman, A., Rutherford, M., Liu, F., Zelinski, S., and McKay, J. (1999). Revisiting the effectiveness of methadone treatment on crime reductions in the 1990's. Journal of Substance Abuse Treatment, 16(4), 329-335.
  
  
• Rothon, D.A., Mathias, R.G., and Schechter, M.T.(1994). Prevalence of HIV infection in provincial prisons in British Columbia. Canadian Medical Association Journal, 151 (6),781-787.
  
  
• Rothon, D.A., Strathdee, S.A., Cook, D., and Cornelisse, P.G.A. (1997). Determinants of HIV-related high-risk behaviours among young offenders: A window of opportunity. Canadian Journal of Public Health, 88(1), 14-17.
  
  
• Salsitz, E.A., Joseph, H., Frank, B., Perez, J., Richman, B.L., Salomon, N., Kalin, M.F, and Novick, D.M. (2000). Methadone medical maintenance (MMM): Treating chronic opioid dependence in private medical practice - a summary report (1983-1998). The Mount Sinai Journal of Medicine 67 (5 and 6), 388-397.
  
  
• Serpelloni, G., Carrieri, M.P., Rezza, G., Morganti, S., Gomma, M., and Binkin, N. (1994). Methadone treatment as a determinant of HIV risk reduction among injecting drug users: a nested case-control study. AIDS Care, 6 (2), 215-220.
  
  
• Sherman, M., and McSherry, J. (1999, August 24). Q and A: Treating hepatitis C. The Medical Post, Q1-Q7.
  
  
• Single, E. (1999). The economic implications of injection drug use. In L. Chabot (Ed.), Injection drug use: Societal challenges (pp.57-68). Montreal: University of Montreal, Faculty of Continuing Education, Drug Addiction Certificate Program.
  
  
• Stitzer, M. L., and Chutuape, M. A. (1999). Other substance use disorders in methadone treatment: prevalence, consequences, detection and management. In E. C. Strain and M. L. Stitzer (Eds.), Methadone Treatment for Opioid Dependence (pp. 86-117). Baltimore: The Johns Hopkins University Press.
  
  
• Stoller, K. B., and Bigelow, G. E. (1999). Regulatory, cost, and policy issues. In E. C. Strain and M. L. Stitzer (Eds.), Methadone Treatment for Opioid Dependence (pp.15-37). Baltimore: The Johns Hopkins University Press.
  
  
• Strain, E.C. (1999a). Beginning and ending methadone dosing: Induction and withdrawal. In E.C. Strain and M. L. Stitzer (Eds.), Methadone treatment for opioid dependence (pp. 53-61). Baltimore: The Johns Hopkins University Press.
  
  
• Strain, E. C. (1999b). Methadone dose during maintenance treatment. In E.C. Strain and M.L. Stitzer (Eds.), Methadone Treatment for Opioid Dependence (pp. 62-85). Baltimore: The Johns Hopkins University Press.
  
  
• Strain, E. C., and Stitzer, M. L. (Eds.) (1999). Methadone Treatment for Opioid Dependence. Baltimore: The Johns Hopkins University Press.
  
  
• Strain, E.C., and Stoller, K.B. (1999). Introduction and historical overview. In E. C. Strain and M. L. Stitzer (Eds.), Methadone Treatment for Opioid Dependence (pp.1-13). Baltimore: The Johns Hopkins University Press.
  
  
• Strain, E. C., Bigelow, G. E., Liebson, I. A., and Stitzer, M. L. (1999). Moderate- vs high-dose methadone in the treatment of opioid dependence. The Journal of the American Medical Association, 281(11), 1000-5.
  
  
• Walsh, S. L, and Strain, E. C. (1999). The Pharmacology of methadone. In E.C. Strain and M.L. Stitzer (Eds.), Methadone Treatment for Opioid Dependence (pp. 38-51). Baltimore: The Johns Hopkins University Press.
  
  
• Ward, J., Mattick R.P., and Hall, W. (1998a). Assessment for opioid replacement therapy. In J. Ward, R.P. Mattick, and W. Hall (Eds.), Methadone Maintenance Treatment and Other Opioid Replacement Therapies (pp. 177-203). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  
  
• Ward, J., Mattick, R.P., and Hall, W. (1998b). How long is long enough? Answers to questions about the duration of methadone maintenance treatment. In J. Ward, R.P. Mattick, and W. Hall (Eds.), Methadone Maintenance Treatment and Other Opioid Replacement Therapies (pp. 305-336). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  
  
• Ward, J., Mattick, R.P., and Hall, W. (1998c). Making the transition from maintenance to abstinence: Detoxification from methadone maintenance treatment. In J. Ward, R.P. Mattick, and W. Hall (Eds.), Methadone Maintenance Treatment and Other Opioid Replacement Therapies (pp. 337-358). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  
  
• Ward, J., Mattick, R.P., and Hall, W. (1998d). Methadone maintenance during pregnancy. In J. Ward, R.P. Mattick, and W. Hall (Eds.), Methadone Maintenance Treatment and Other Opioid Replacement Therapies (pp. 397-416). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  
  
• Ward, J., Mattick, R.P., and Hall, W. (Eds.). (1998e). Methadone Maintenance Treatment and Other Opioid Replacement Therapies. Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  
  
• Ward, J., Mattick, R. P., and Hall, W. (1998f). Psychiatric comorbidity among the opioid dependent . In J. Ward, R.P. Mattick, and W. Hall (Eds.), Methadone Maintenance Treatment and Other Opioid Replacement Therapies (pp. 419-440). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  
  
• Ward J., Mattick R.P., and Hall W. (1998g). The effectiveness of methadone maintenance treatment 2: HIV and infectious hepatitis. In J. Ward, R.P. Mattick, and W. Hall (Eds.), Methadone Maintenance Treatment and Other Opioid Replacement Therapies (pp. 59-73). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  
  
• Ward, J., Mattick, R.P., and Hall, W. (1998h). The use of methadone during maintenance treatment: Pharmacology, dosage and treatment outcome. In J. Ward, R.P. Mattick, and W. Hall (Eds.), Methadone Maintenance Treatment and Other Opioid Replacement Therapies (pp. 205-238). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  
  
• Ward, J., Mattick, R.P., and Hall, W. (1998i). The use of urinalysis during opioid replacement therapy. In J. Ward, R.P. Mattick, and W. Hall (Eds.), Methadone Maintenance Treatment and Other Opioid Replacement Therapies (pp. 239-264). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  
  
• Ward, P., and Sutton, M. (1998). The effectiveness of methadone maintenance treatment 4: Cost-effectiveness. In J. Ward, R.P. Mattick, and W. Hall (Eds.), Methadone Maintenance Treatment and Other Opioid Replacement Therapies (pp. 91-121). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  
  
• Wells, E., Calsyn, D.A., and Clark, L.L.. (1996). Retention in methadone maintenance is associated with reductions in different HIV risk behaviours for women and men. American Journal of Drug and Alcohol Abuse, 22 (4), 509-521.